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Abstract
Background: A displaced femoral neck fracture (FNF) in patients 55-70 years is a serious injury with a high risk
of treatment failure and the optimal surgical treatment remains unclear. We aimed to describe characteristics of
fracture patients compared to a sample from the normal population.
Methods: Fifty patients aged 55-70 years with a displaced FNF were gender- and age- matched with a control group
of 150 persons without a hip fracture using computergenerated randomization and the Norwegian National Population
Register. To reduce the risk of spurious selection bias, the sample size of the control group was trebled compared to
the fracture group. Dual-energy x-ray absorptiometry (DXA) was performed. Demographics and hip function (Harris Hip
Score, Oxford Hip Score, and Hip Dysfunction and Osteoarthritis Outcome Score) were collected.
Results: There were more than 75% women in both groups. The mean age was 64.5 years in the fracture group and
65.1 in the control group. Results for DXA measured for lumbar spine, total hip and the femoral neck showed
that patients with displaced FNF were significantly more osteoporotic. Fracture patients had significantly lower
body mass index, higher Charlson comorbidity index (CCI), and higher ASA (American Society of Anesthesiologists) score
than the control group. No clinically relevant differences in hip function were found. There were 48% smokers in the
fracture group compared to 10% in the control group. The odds ratio for obtaining a displaced FNF was high if the
patients suffered from osteoporosis, smoked or had several comorbidities.
Conclusions: This study showed that patients aged 55-70 years with a displaced femoral neck fracture had lower bone
density and higher comorbidity compared with a gender- and age-matched population without femoral neck fractures.
This suggests that this patient group is epidemiologically similar to older patients with femoral neck fractures.
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Background
Regardless of age, a displaced femoral neck fracture
(FNF) is a severe injury and will almost always require
hospitalization and surgery [1]. Patients with these fractures
have a high risk of subsequent surgical complications,
reduced function, hip pain and reduced health-related qual-
ity of life. The health economic aspect is a great challenge,
even though the overall incidence of hip fractures has
decreased in recent decades [1–7]. The literature on elderly
patients older than 70 years with displaced FNFs is exten-
sive and arthroplasty is clearly recommended as the treat-
ment of choice [8–14]. The middle-aged patient group
aged 55-70 years is less well described and the treatment
for displaced FNFs is still controversial [11–13]. These
patients are probably still working and demand a high level
of activity. A Norwegian study has reported the overall hip
fracture incidence in this particular age group to be 92 per
10 000 (53 women and 39 men) in the period 2009-2013
[15]. We found a specific incidence of about 6.1 fractures
for both genders per 10 000 for displaced FNFs in patients
55-70 years in 2017 in Norway [16, 17]. Most of these FNFs
are caused by a low-energy trauma, and the patients often
have other diseases and factors, such as medication (ste-
roids, anti-epileptic medication), alcoholism, other sub-
stance abuse, or osteoporosis, all of which may increase
the risk of complications, including revision surgery
[18–20]. Studies including bone density at the time of
fracture are rare and often described a more geriatric
population [21]. For patients under 60 years of age,
internal fixation (IF) is usually recommended, as many
surgeons endeavor to prevent replacement of the hip
joint [12, 13, 22]. Studies investigating outcome after
FNF in patients younger than 70 years have found a
high risk of reoperation after IF due to mechanical
failure, non-union or avascular necrosis [22–24]. Most
of the investigated patients in this age group had symp-
tomatic comorbidities and the 1-year mortality has
been reported to be as high as 15% [24]. This may indi-
cate that many hip fracture patients under 70 years of
age are more osteoporotic and frailer than individuals
at the same age in the general population. Thus, their
fractures may beneficially be treated mainly by arthro-
plasty, as in patients older than 70 years.
The aim of the present study was to describe differ-
ences in bone density and morbidity at the time of injury
between a group of 50 patients aged 55-70 with a native
intracapsular displaced FNF compared with a gender-
and age- matched cohort of 150 participants from the
general population without a fracture.
Methods
This pragmatic gender- and age- matched case-control
included 50 consecutive patients aged 50-70 years
presenting with a low-energy displaced FNF in the native
hip joint and belonging to the catchment area of Akershus
University Hospital, Norway from December 2013 to No-
vember 2017. The control group consisted of 150 partici-
pants from the population in the same catchment area.
The Department of Data and Analytics at Akershus Uni-
versity Hospital was responsible for the recruitment of this
group using computergenerated randomization lists and
both the National Population Register and the unique na-
tional identification number assigned for each inhabitant in
Norway. Patients with cognitive impairment were not in-
cluded in either group. Controls were matched to the frac-
ture group by loose matching [25]. For matching we
divided the patients into three age groups for both genders
(55-59, 60-64, 65-69 years) using the number of cases in
the fracture group as the base. The tripled size of the con-
trol group was chosen to achieve statistical power [26].
Three hundred and forty-one potential participants were
invited by mail, and one hundred and ninety-one persons
declined or did not attend the agreed appointment. Infor-
mation from the FNF patients was collected before dis-
charge. DXA was performed postoperatively before
discharge or within at least 6 weeks after injury. No anti-
osteoporotic medication was given to the fracture patients
group before DXA was performed. Interviews, question-
naires, and DXA for the control group were performed be-
tween November 2016 and June 2017 during a single
outpatient appointment. All participants in the control
group and in the fracture group signed an informed con-
sent form.
The following variables were registered: age, gender,
height and weight (measured in conjunction with DXA
using a standard scale and a stadiometer), current smok-
ing status, Charlson comorbidity index (CCI), American
Society of Anesthesiologists (ASA) score and presence of
diabetes [27, 28]. Furthermore, the Harris Hip Score
(HHS), Oxford Hip Score and the Hip Dysfunction and
Osteoarthritis Outcome Score (HOOS) were recorded
[29–31]. For patients with displaced FNF, we asked for
specific hip function scores the last week before the
current fracture. Body Mass Index (BMI) was calculated
as weight/height2 in kg/m2. Each participant in the
control group and patients in the fracture group under-
went a DXA measurement using lumbar spine (L1-L4),
total hip and femoral neck. Five patients in the fracture
group could not undergo DXA measurement in the hip,
due to implants after recent fracture care and from
previous surgery unrelated to the recent injury in the
contralateral side.
The DXA scan was used to determine bone mineral
density (BMD) measured in the lumbar spine (L1-L4),
total hip and the femoral neck. All BMD measurements
were performed by two independent DXA technicians
on the same DXA scanner (Lunar iDXA™ GE Healthcare
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Lunar, Global Headquarters, P O Box 7550, Madison,
Wisconsin 53707-7550, USA).
The definition of osteoporosis was that used by the
World Health Organization, where a T-score ≤ - 2.5 SD
is osteoporosis, a T-score > - 2.5 - < - 1 SD is osteopenia
and T-score ≥ - 1 SD is normal bone [32].
Statistical analysis
Continuous variables are presented as mean values and
categorical variables were summarized by the number of
subjects and percentage in each category. We used the
independent samples t-test for continuous variables with
normal distribution, and the Mann-Whitney U-test for
Fig. 1 Differences in comorbidity presented by ASA classification in % for both groups
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non-normally distributed outcomes. The Pearson Chi-
square test was used for categorical variables. All tests
were two-sided and results were considered statistically
significant at a 5% level. To identify risk factors for a
femoral neck fracture we used a logistic regression model
with independent variables. The Odds Ratios (ORs) and
the 95% Confidence Intervals (CIs) were reported. The
analyses were performed using IBM SPSS, version 25.0
(IBM Corp., Armonk, NY, USA).
Results
Comorbidity
We found more comorbidities (higher CCI score and
more patients with ASA class 2-3) in the fracture group
(Table 1) (Fig. 1). Patients in the fracture group had
lower BMI and there were more smokers in this group.
Hip function
No significant differences in hip function using the Oxford
Hip Score and HOOS could be found, but the control
group reported better HHS (97.1) compared to the frac-
ture group (93.6) (Table 2) (Fig. 2).
Bone mineral density
BMD measurements were performed for all participants
in the control group. Five participants in the fracture
group had implants in both hips, making measurements
in this area impossible. There were more patients with
osteopenia and osteoporosis in the fracture group com-
pared to the control group both when comparing results
from lumbar spine, total hip, and the femoral neck
(Table 3) (Fig. 3).
Risk analysis
A multivariate logistic regression analysis for unadjusted
variables showed statistically significant differences in
the OR for smoking, presence of osteoporosis, and CCI
score (Table 4). The adjusted OR for obtaining a femoral
neck fracture was 6.7 for smokers compared to non-
smokers, and 7.5 for participants with osteoporosis
compared to participants with normal BMD.
Discussion
The present study showed that patients aged 55-70 years
with a displaced FNF were more osteoporotic and had
more comorbidities compared to a gender- and age-
Fig. 2 Differences in hip function presented by HOOS for both groups and before fracture
Table 2 Differences in hip function between cases (before fracture) and controls
Fracture group n = 50 Control group n = 150 p-values
Mean Harris Hip Score (95% CI) 93.6 (91.0-96.3) 97.1 (95.8-98.4) < 0.001a
Mean Oxford Hip Score (95% CI) 46.2 (44.8-47.2) 46.0 (45.4-47.0) 0.173 a
Mean HOOS (95%CI) Pain 92.9 (89.1-96.7) 95.3 (93.5-97.1) 0.226 a
Symptoms 94.3 (90.6-97.7) 95.2 (93.4-97.0) 0.226 a
ADL 92.4 (87.3-97.5) 95.7 (93.9-97.5) 0.244 a
Sport 89.9 (83.6-96.2) 92.1 (89.3-94.8) 0.739 a
QoL 94.0 (89.7-98.4) 93.6 (90.9-96.4) 0.792 a
aMann-Whitney U-test
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matched control group. In addition, we found that
fracture patients were more frequently smokers and had
lower BMI. Thus, our data suggests that the risk of
sustaining a displaced femoral neck fracture probably
increases with the presence of osteoporosis, comorbidi-
ties and smoking. Regarding baseline hip function, the
control group reported better scores in only one of the
three hip scores used, suggesting that the difference was
not clinically relevant.
There were statistically significantly more patients
with low bone density in the fracture group. These
findings agree well with other studies suggesting that
young patients (< 50 years of age) with hip fracture due
to low-energy injury suffer from early osteoporosis
[18, 20]. We found more comorbidities in the fracture
group, measured by both the CCI score and the ASA
score. These findings are supported by another study
reporting comorbidities as an important and determin-
ant factor in non-elderly patients with hip fractures
[20]. We found a significantly higher proportion of
smokers in the fracture group, where almost 50% were
smokers at the time of injury compared to 10% in the
control group. This has also been confirmed by a
meta-analysis identifying smoking as a risk factor for
any kind of fracture and for hip fractures in particular
[33]. Other authors have postulated smoking and
diabetes mellitus as the strongest independent impact
factors for increased hip fracture risk [34, 35]. Diabetes
has previously been described as an important risk fac-
tor for hip fractures in both women and men [35–37].
A statistically significant difference in the presence of
diabetes between the fracture group and the control
Fig. 3 T-score values for fracture and control group
Table 3 Differences in DXA-measures between 50 patients with FNF and the control group
Dual-energy X-ray absorptiometry Fracture group






Lumbar spine T-score 0.003 a
T-score >-1 19 (38%) 83 (55%)
T-score - 1- -2.5 17 (34%) 53 (35%)
T-score≤ -2.5 14 (28%) 14 (9%)
Hip total T-score b < 0.001 a
T-score >-1 8 (18%) 79 (53%)
T-score - 1 - -2.5 22 (49%) 63 (42%)
T-score≤ -2.5 15 (33%) 8 (5%)
Hip femoral neck T-score b < 0.001 a
T-score >-1 4 (9%) 47 (31%)
T-score- 1 - -2.5 21 (47%) 85 (57%)
T-score≤ -2.5 20 (44%) 18 (12%)
aPearson Chi-square test
b5 patients with implants after fracture care in both hips, making measurements in the hips impossible
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group could not be found in our study. However, as
we had a limited number of participants in our study,
the power was probably insufficient to investigate this
issue.
Lower BMI was found in the fracture group. Higher
BMI has been argued to protect against a hip fracture,
but probably not in this age group [38]. The lower BMI
might also be associated with the larger number of
smokers in the fracture group. Smoking is associated
with negative influence on nutrition, which may result in
lower BMI among smokers [33].
Our study suggests that the presence of osteoporosis
and smoking were the strongest differences between
the fracture group and the control group with a seven
times higher OR for patients with displaced FNF when
adjusting for smoking, comorbidity and BMD.
The main strength of our study is that the DXA measure-
ments in the fracture group were performed at the time of
injury, documenting the current bone status. Furthermore,
we present results from a representative and relatively
homogeneous gender- and age-matched population.
However, this study has limitations, as case-control
studies are prone to bias, especially selection and recall
bias. The number of fracture patients was limited, as
the incidence of hip fractures in this age group is low
[19]. The sample size was small and included both
genders, recognizing the differences in risk factors and
epidemiology of hip fracture in women and men [15,
18, 38, 39]. Exact power calculations were not per-
formed, but tripling the number of controls was used
to improve statistical strength [26]. We used a stand-
ard logistic regression model for a loose-matching
strategy within pair correlation, approving that condi-
tional logistic regression is the appropriate analytical
method for matched case-control studies. We did not
record several well-known risk factors for hip fractures
and osteoporosis, such as alcohol consumption, calcium
and vitamin D levels, differences in bone-associated co-
morbidities (e.g. malabsorption), hormonal deficits, or
the use of specific medication influencing bone quality
(steroids, anti-epileptic medication) [20, 34, 35, 39–41].
Conclusions
Patients between 55 and 70 years with a displaced femoral
neck fracture were more osteoporotic and have more co-
morbidities, than a comparable gender- and age- matched
group from the general population without a femoral neck
fracture. Our data indicate that these patients are frailer
than expected and should probably not be compared with
their peers of the same age. From a clinical perspective,
patients aged 55-70 years may benefit from a similar treat-
ment as those over 70 years, within a treatment algorithm
considering biological age, individual factors, and medical
challenges.
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